UAN heads into today's confirmed earnings call with a cleaner short book and a dividend score that stands out in the fertilizer space — and the Q1 numbers already out show why bears have been in retreat.
CVR Partners reported Q1 2026 EPS of $4.72, nearly double the $2.56 posted a year ago, on revenue of $180 million versus $143 million in Q1 2025. That is a meaningful year-on-year acceleration. The stock closed at $133.27 on April 29, up 4.7% on the week but still about 2.7% softer on the month — suggesting the market had partly priced in improvement, even if not the full magnitude.
The short side of the trade has been winding down. Short interest fell 8.2% over the past week to roughly 216,000 shares. At 2.1% of the free float, it was never a crowded bet, and borrow availability is extraordinarily loose — available shares run at more than 2,850% of current short interest, well above any threshold that would signal squeeze pressure. Days to cover at 2.15 are minimal. The ORTEX short score of 34.5 — sitting in the 36th percentile — reflects a market in which short sellers are not making a particularly aggressive directional call against this name. Cost to borrow has jumped from near zero mid-April to 2.4% now, a 418% monthly climb, but the absolute level remains unremarkable for a $1.4 billion market cap partnership.
Icahn Capital, holding 39.4% of shares, has not moved its position in over a year. That concentration tells a simple story: the stock goes where Icahn lets it go. Morgan Stanley trimmed 44,667 shares in its most recent filing, while ING and Susquehanna have been adding modestly. There is no institutional churn that changes the fundamental read. The dividend score of 75 — in the top quarter of the universe — matters here because CVR Partners is a variable-distribution MLP; investors care acutely about what free cash flow translates into at the distribution level, not just EPS optics.
Options positioning offers a mild note of caution. The put/call ratio of 0.22 is above its 20-day average of 0.19, with a z-score of 1.1 — above normal but well short of the defensive extremes that would suggest real anxiety. The 52-week PCR high is 0.94, so the current reading is far from that level. Peers CF and LXU both rallied on the day, up 3.7% and 2.4% respectively, while UAN dipped 0.7% — a mild underperformance heading into the release. The Q2 distribution announcement, not just the EPS headline, is what the print ultimately tests for this variable-payout MLP.
See the live data behind this article on ORTEX.
Open UAN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
